The role of nonrandomized trials in the evaluation of oncology drugs. [electronic resource]
Producer: 20150625Description: 502-7 p. digitalISSN:- 1532-6535
- Antineoplastic Agents -- adverse effects
- Clinical Trials as Topic -- methods
- Drug Approval
- Endpoint Determination
- Evidence-Based Medicine -- methods
- Humans
- Medical Oncology -- methods
- Neoplasms -- drug therapy
- Practice Guidelines as Topic
- Research Design -- standards
- Risk Assessment
- Risk Factors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.